SCHEMBL14103758

SCHEMBL14103758

N#Cc1ccc(Oc2nc(-c3cccc(Br)c3)nc3ccsc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 3/20 0.43
▸ MAPT P10636 3/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ CYP1A2 P05177 4/20 0.38
▸ CYP3A4 P08684 4/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PRKCI P41743 3/20 0.36
▸ PDE10A Q9Y233 1/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ ADORA2A P29274 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ PIK3CA P42336 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4783849 0.87 MAPT (0.49) ABCG2MAPTL3MBTL1HTTCYP1A2
SCHEMBL14105450 0.87 ABCG2 (0.57) ABCG2MAPTL3MBTL1HTTCYP1A2
SCHEMBL4740912 0.85 ABCG2 (0.35) ABCG2MAPTCYP1A2CYP3A4CYP2C9
SCHEMBL4574102 0.82 MAPT (0.50) ABCG2MAPTL3MBTL1HTTCYP1A2
SCHEMBL4575030 0.81 KDM4E (0.44) MAPTL3MBTL1HTTCYP1A2CYP3A4
SCHEMBL4740942 0.80 PTGS1 (0.46) ABCG2MAPTL3MBTL1HTTCYP1A2
SCHEMBL4740291 0.80 PTGS1 (0.46) ABCG2MAPTL3MBTL1HTTCYP1A2
SCHEMBL14104181 0.80 RXFP1 (0.55) ABCG2MAPTL3MBTL1HTTCYP1A2
SCHEMBL11990374 0.80 PRKCI (0.45) MAPTL3MBTL1HTTCYP1A2CYP3A4
SCHEMBL9881228 0.80 PRKCI (0.43) MAPTL3MBTL1HTTCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008092861-A1 BICYCLIC DERIVATIVES AS EP4 AGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-07 — — WO disclosed
Send feedback